﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2023v6.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2025-02-18T13:56:04-06:00</ReturnTs>
    <TaxPeriodEndDt>2024-03-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>042571780</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>AAFCPAS INC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>50 WASHINGTON STREET</AddressLine1Txt>
        <CityNm>WESTBOROUGH</CityNm>
        <StateAbbreviationCd>MA</StateAbbreviationCd>
        <ZIPCd>01581</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-04-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>463630772</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>ZOLL FOUNDATION INC</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>ZOLL</BusinessNameControlTxt>
      <PhoneNum>9784219361</PhoneNum>
      <USAddress>
        <AddressLine1Txt>269 MILL ROAD</AddressLine1Txt>
        <CityNm>CHELMSFORD</CityNm>
        <StateAbbreviationCd>MA</StateAbbreviationCd>
        <ZIPCd>01824</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>JOHN BERGERON</PersonNm>
      <PersonTitleTxt>TREASURER</PersonTitleTxt>
      <PhoneNum>9784219361</PhoneNum>
      <SignatureDt>2025-02-18</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>1</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>CHRISTOPHER CONSOLETTI ESQ</PreparerPersonNm>
      <PTIN>P02060442</PTIN>
      <PhoneNum>5083669100</PhoneNum>
      <PreparationDt>2025-02-18</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="9">
    <IRS990PF documentId="RetDoc1235000001">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>27489167</FMVAssetsEOYAmt>
      <MethodOfAccountingCashInd>X</MethodOfAccountingCashInd>
      <AnalysisOfRevenueAndExpenses>
        <ContriRcvdRevAndExpnssAmt>0</ContriRcvdRevAndExpnssAmt>
        <ScheduleBNotRequiredInd>X</ScheduleBNotRequiredInd>
        <DividendsRevAndExpnssAmt>694897</DividendsRevAndExpnssAmt>
        <DividendsNetInvstIncmAmt>694897</DividendsNetInvstIncmAmt>
        <NetGainSaleAstRevAndExpnssAmt>114773</NetGainSaleAstRevAndExpnssAmt>
        <GrossSalesPriceAmt>1237632</GrossSalesPriceAmt>
        <CapGainNetIncmNetInvstIncmAmt>114773</CapGainNetIncmNetInvstIncmAmt>
        <OtherIncomeRevAndExpnssAmt referenceDocumentId="RetDoc2001500001">2000</OtherIncomeRevAndExpnssAmt>
        <OtherIncomeNetInvstIncmAmt>0</OtherIncomeNetInvstIncmAmt>
        <TotalRevAndExpnssAmt>811670</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>809670</TotalNetInvstIncmAmt>
        <CompOfcrDirTrstRevAndExpnssAmt>0</CompOfcrDirTrstRevAndExpnssAmt>
        <CompOfcrDirTrstNetInvstIncmAmt>0</CompOfcrDirTrstNetInvstIncmAmt>
        <CompOfcrDirTrstDsbrsChrtblAmt>0</CompOfcrDirTrstDsbrsChrtblAmt>
        <AccountingFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002200001">7000</AccountingFeesRevAndExpnssAmt>
        <AccountingFeesNetInvstIncmAmt>0</AccountingFeesNetInvstIncmAmt>
        <AccountingFeesChrtblPrpsAmt>7000</AccountingFeesChrtblPrpsAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="RetDoc2002500001">19</TaxesRevAndExpnssAmt>
        <TaxesNetInvstIncmAmt>0</TaxesNetInvstIncmAmt>
        <TaxesDsbrsChrtblAmt>19</TaxesDsbrsChrtblAmt>
        <TravConfMeetingRevAndExpnssAmt>2005</TravConfMeetingRevAndExpnssAmt>
        <TravConfMeetingNetInvstIncmAmt>0</TravConfMeetingNetInvstIncmAmt>
        <TravConfMeetingDsbrsChrtblAmt>2005</TravConfMeetingDsbrsChrtblAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="RetDoc2003200001">123523</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesNetInvstIncmAmt>93094</OtherExpensesNetInvstIncmAmt>
        <OtherExpensesDsbrsChrtblAmt>30429</OtherExpensesDsbrsChrtblAmt>
        <TotOprExpensesRevAndExpnssAmt>132547</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>93094</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>39453</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>1561412</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>1561412</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>1693959</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>93094</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>1600865</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>-882289</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>716576</NetInvestmentIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <CashBOYAmt>190395</CashBOYAmt>
        <CashEOYAmt>83452</CashEOYAmt>
        <CashEOYFMVAmt>83452</CashEOYFMVAmt>
        <SavAndTempCashInvstBOYAmt>569980</SavAndTempCashInvstBOYAmt>
        <SavAndTempCashInvstEOYAmt>318962</SavAndTempCashInvstEOYAmt>
        <SavAndTempCashInvstEOYFMVAmt>318962</SavAndTempCashInvstEOYFMVAmt>
        <CorporateStockBOYAmt>24951458</CorporateStockBOYAmt>
        <CorporateStockEOYAmt referenceDocumentId="RetDoc2018900001">27086753</CorporateStockEOYAmt>
        <CorporateStockEOYFMVAmt>27086753</CorporateStockEOYFMVAmt>
        <TotalAssetsBOYAmt>25711833</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>27489167</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>27489167</TotalAssetsEOYFMVAmt>
        <AccountsPayableBOYAmt>5777</AccountsPayableBOYAmt>
        <TotalLiabilitiesBOYAmt>5777</TotalLiabilitiesBOYAmt>
        <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
        <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
        <NoDonorRstrNetAssestsBOYAmt>25706056</NoDonorRstrNetAssestsBOYAmt>
        <NoDonorRstrNetAssestsEOYAmt>27489167</NoDonorRstrNetAssestsEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>25706056</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>27489167</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>25711833</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>27489167</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>25706056</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>-882289</ExcessRevenueOverExpensesAmt>
        <OtherIncreasesAmt referenceDocumentId="RetDoc2049700001">2665400</OtherIncreasesAmt>
        <SubtotalAmt>27489167</SubtotalAmt>
        <OtherDecreasesAmt>0</OtherDecreasesAmt>
        <TotNetAstOrFundBalancesEOYAmt>27489167</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <CapGainsLossTxInvstIncmDetail>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SALE OF EQUITIES</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <GrossSalesPriceAmt>1237632</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1122859</CostOrOtherBasisAmt>
          <GainOrLossAmt>114773</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>114773</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapitalGainNetIncomeAmt>114773</CapitalGainNetIncomeAmt>
      </CapGainsLossTxInvstIncmDetail>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>9960</InvestmentIncomeExciseTaxAmt>
        <TaxUnderSection511Amt>0</TaxUnderSection511Amt>
        <SubtotalAmt>9960</SubtotalAmt>
        <SubtitleATaxAmt>0</SubtitleATaxAmt>
        <TaxBasedOnInvestmentIncomeAmt>9960</TaxBasedOnInvestmentIncomeAmt>
        <EstimatedPlusOvpmtIncmTxAmt>16989</EstimatedPlusOvpmtIncmTxAmt>
        <ExemptFrgnOrgTaxWthldAtSrceAmt>0</ExemptFrgnOrgTaxWthldAtSrceAmt>
        <ExtsnRequestIncomeTaxPaidAmt>0</ExtsnRequestIncomeTaxPaidAmt>
        <BackupWithholdingWithheldAmt>0</BackupWithholdingWithheldAmt>
        <TotalPaymentsAndCreditsAmt>16989</TotalPaymentsAndCreditsAmt>
        <EsPenaltyAmt>0</EsPenaltyAmt>
        <OverpaymentAmt>7029</OverpaymentAmt>
        <AppliedToESTaxAmt>7029</AppliedToESTaxAmt>
        <RefundAmt>0</RefundAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>0</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>0</MoreThan100SpentInd>
        <Form1120POLFiledInd>0</Form1120POLFiledInd>
        <Section4955OrganizationTaxAmt>0</Section4955OrganizationTaxAmt>
        <Section4955ManagersTaxAmt>0</Section4955ManagersTaxAmt>
        <TaxReimbursedAmt>0</TaxReimbursedAmt>
        <ActivitiesNotPreviouslyRptInd>0</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>0</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
        <OrganizationDissolvedEtcInd>0</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>1</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>1</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>MA</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>1</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>0</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd referenceDocumentId="RetDoc2089200001">1</NewSubstantialContributorsInd>
        <OwnControlledEntityInd>0</OwnControlledEntityInd>
        <DonorAdvisedFundInd>0</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>1</ComplyWithPublicInspRqrInd>
        <WebsiteAddressTxt>ZOLLFOUNDATION.ORG</WebsiteAddressTxt>
        <IndividualWithBooksNm>JOHN BERGERON</IndividualWithBooksNm>
        <PhoneNum>7812723178</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>269 MILL ROAD</AddressLine1Txt>
          <CityNm>CHELMSFORD</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>01824</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>0</ForeignAccountsQuestionInd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>0</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>0</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>0</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>0</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>0</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>0</PaymentToGovernmentOfficialInd>
        <UncorrectedPriorActsInd>0</UncorrectedPriorActsInd>
        <UndistributedIncomePYInd>0</UndistributedIncomePYInd>
        <BusinessHoldingsInd>0</BusinessHoldingsInd>
        <JeopardyInvestmentsInd>0</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>0</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>0</InfluenceLegislationInd>
        <InfluenceElectionInd>0</InfluenceElectionInd>
        <GrantsToIndividualsInd>0</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>1</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>0</NoncharitablePurposeInd>
        <TransactionsFailToQlfyAsExcInd>1</TransactionsFailToQlfyAsExcInd>
        <MaintainedExpenditureRspnsInd referenceDocumentId="RetDoc2118100001">1</MaintainedExpenditureRspnsInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
        <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>RICHARD PACKER</PersonNm>
          <USAddress>
            <AddressLine1Txt>269 MILL ROAD</AddressLine1Txt>
            <CityNm>CHELMSFORD</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01824</ZIPCd>
          </USAddress>
          <TitleTxt>CLERK/DIRECTOR</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>JOHN BERGERON</PersonNm>
          <USAddress>
            <AddressLine1Txt>269 MILL ROAD</AddressLine1Txt>
            <CityNm>CHELMSFORD</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01824</ZIPCd>
          </USAddress>
          <TitleTxt>TREASURER/DIRECTOR</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>WARD HAMILTON</PersonNm>
          <USAddress>
            <AddressLine1Txt>269 MILL ROAD</AddressLine1Txt>
            <CityNm>CHELMSFORD</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01824</ZIPCd>
          </USAddress>
          <TitleTxt>PRESIDENT/DIRECTOR</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>COREEN PACKER</PersonNm>
          <USAddress>
            <AddressLine1Txt>269 MILL ROAD</AddressLine1Txt>
            <CityNm>CHELMSFORD</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01824</ZIPCd>
          </USAddress>
          <TitleTxt>DIRECTOR</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>NORMAN PARADIS</PersonNm>
          <USAddress>
            <AddressLine1Txt>269 MILL ROAD</AddressLine1Txt>
            <CityNm>CHELMSFORD</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01824</ZIPCd>
          </USAddress>
          <TitleTxt>DIRECTOR</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>JON RENNERT</PersonNm>
          <USAddress>
            <AddressLine1Txt>269 MILL ROAD</AddressLine1Txt>
            <CityNm>CHELMSFORD</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01824</ZIPCd>
          </USAddress>
          <TitleTxt>DIRECTOR</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>FUMITO ICHINOSE MD</PersonNm>
          <USAddress>
            <AddressLine1Txt>269 MILL ROAD</AddressLine1Txt>
            <CityNm>CHELMSFORD</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01824</ZIPCd>
          </USAddress>
          <TitleTxt>DIRECTOR</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompOfHghstPdEmplOrNONETxt>NONE</CompOfHghstPdEmplOrNONETxt>
        <OtherEmployeePaidOver50kCnt>0</OtherEmployeePaidOver50kCnt>
        <CompOfHghstPdCntrctOrNONETxt>NONE</CompOfHghstPdCntrctOrNONETxt>
        <ContractorPaidOver50kCnt>0</ContractorPaidOver50kCnt>
      </OfficerDirTrstKeyEmplInfoGrp>
      <SumOfProgramRelatedInvstGrp>
        <TotalAmt>0</TotalAmt>
      </SumOfProgramRelatedInvstGrp>
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>26228782</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>272744</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>0</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>26501526</TotalFMVOfUnusedAssetsAmt>
        <ReductionClaimedAmt>0</ReductionClaimedAmt>
        <AcquisitionIndebtednessAmt>0</AcquisitionIndebtednessAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>26501526</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>397523</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>26104003</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>1305200</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <MinimumInvestmentReturnAmt>1305200</MinimumInvestmentReturnAmt>
        <TaxBasedOnInvestmentIncomeAmt>9960</TaxBasedOnInvestmentIncomeAmt>
        <TotalTaxAmt>9960</TotalTaxAmt>
        <DistributableBeforeAdjAmt>1295240</DistributableBeforeAdjAmt>
        <RecoveriesQualfiedDistriAmt>2000</RecoveriesQualfiedDistriAmt>
        <DistributableBeforeDedAmt>1297240</DistributableBeforeDedAmt>
        <DeductionFromDistributableAmt>0</DeductionFromDistributableAmt>
        <DistributableAsAdjustedAmt>1297240</DistributableAsAdjustedAmt>
      </DistributableAmountGrp>
      <PFQualifyingDistributionsGrp>
        <ExpensesAndContributionsAmt>1600865</ExpensesAndContributionsAmt>
        <ProgramRelatedInvstTotalAmt>0</ProgramRelatedInvstTotalAmt>
        <QualifyingDistributionsAmt>1600865</QualifyingDistributionsAmt>
      </PFQualifyingDistributionsGrp>
      <UndistributedIncomeGrp>
        <DistributableAsAdjustedAmt>1297240</DistributableAsAdjustedAmt>
        <UndistributedIncomePYAmt>1329005</UndistributedIncomePYAmt>
        <TotalForPriorYearsAmt>0</TotalForPriorYearsAmt>
        <TotalExcessDistributionCyovAmt>0</TotalExcessDistributionCyovAmt>
        <QualifyingDistributionsAmt>1600865</QualifyingDistributionsAmt>
        <AppliedToYear1Amt>1329005</AppliedToYear1Amt>
        <AppliedToPriorYearsAmt>0</AppliedToPriorYearsAmt>
        <TreatedAsDistriFromCorpusAmt>0</TreatedAsDistriFromCorpusAmt>
        <AppliedToCurrentYearAmt>271860</AppliedToCurrentYearAmt>
        <RemainingDistriFromCorpusAmt>0</RemainingDistriFromCorpusAmt>
        <ExcessDistriCyovAppCYCorpusAmt>0</ExcessDistriCyovAppCYCorpusAmt>
        <ExcessDistributionCyovAppCYAmt>0</ExcessDistributionCyovAppCYAmt>
        <TotalCorpusAmt>0</TotalCorpusAmt>
        <PriorYearUndistributedIncmAmt>0</PriorYearUndistributedIncmAmt>
        <PriorYearDeficiencyOrTaxAmt>0</PriorYearDeficiencyOrTaxAmt>
        <Taxable1Amt>0</Taxable1Amt>
        <Taxable2Amt>0</Taxable2Amt>
        <UndistributedIncomeCYAmt>1025380</UndistributedIncomeCYAmt>
        <CorpusDistri170b1EOr4942g3Amt>0</CorpusDistri170b1EOr4942g3Amt>
        <ExcessDistriCyovFromYr5Amt>0</ExcessDistriCyovFromYr5Amt>
        <ExcessDistriCyovToNextYrAmt>0</ExcessDistriCyovToNextYrAmt>
      </UndistributedIncomeGrp>
      <SupplementaryInformationGrp>
        <ContributingManagerNm>RICHARD PACKER</ContributingManagerNm>
        <OnlyContriToPreselectedInd>X</OnlyContriToPreselectedInd>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AARHUS UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PALLE JUUL-JENSENS BOULEVARD 99</AddressLine1Txt>
            <CountryCd>DA</CountryCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MS LANGKILDE LAUESEN RESEARCH HANDOVER OF INFORMATION FROM WARD STAFF TO THE CARDIAC ARREST TEAM DURING IN-HOSPITAL CARDIAC ARREST: IDENTIFYING DEFICIENCIES AND BUILDING A NEW MODEL</GrantOrContributionPurposeTxt>
          <Amt>27615</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AARHUS UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PALLE JUUL-JENSENS BOULEVARD 99</AddressLine1Txt>
            <CountryCd>DA</CountryCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR JOHANNSEN - REDUCING NEUROLOGICAL INJURY FOLLOWING CARDIAC ARREST</GrantOrContributionPurposeTxt>
          <Amt>48836</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AARHUS UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PALLE JUUL-JENSENS BOULEVARD 99</AddressLine1Txt>
            <CountryCd>DA</CountryCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MR. JENNINGS - A NOVEL RISK ASSESSMENT TOOL FOR HYPERKALAEMIA AND DEVELOPMENT OF CARDIAC ARRHYTHMIA</GrantOrContributionPurposeTxt>
          <Amt>8500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AARHUS UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PALLE JUUL-JENSENS BOULEVARD 99</AddressLine1Txt>
            <CountryCd>DA</CountryCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MR. NORHOLT RESEARCH INTRAMUSCULAR EPINEPHRINE FOR THE TREATMENT OF CARDIAC ARREST</GrantOrContributionPurposeTxt>
          <Amt>46726</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ANTWERP UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>DRIE EIKENSTRAAT 655</AddressLine1Txt>
            <ProvinceOrStateNm>EDEGEM</ProvinceOrStateNm>
            <CountryCd>BE</CountryCd>
            <ForeignPostalCd>2650</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR VERDONCK RESEARCH INJURY-SPECIFIC DIFFERENCES IN THE ADAMTS13-VWF AXIS IN MAJOR TRAUMA PATIENTS</GrantOrContributionPurposeTxt>
          <Amt>51597</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRIGHAM AND WOMEN'S HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>75 FRANCIS ST</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. LEVY - ACTIVATION OF TISSUE-RESIDENT STEM CELLS DURING ACUTE BURN TRAUMA CARE</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRIGHAM AND WOMEN'S HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>75 FRANCIS ST</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. RIKHTEGAR NEZAMI RESEARCH CLINICAL PREDICTORS OF THROMBOSIS IN EXTRACORPOREAL MEMBRANE OXYGENATORS USED FOR ACUTE CRITICAL CARE</GrantOrContributionPurposeTxt>
          <Amt>49911</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHARITE - UNIVERSITATSMEDIZIN BERLIN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>CHARITEPL 1</AddressLine1Txt>
            <ProvinceOrStateNm>BERLIN</ProvinceOrStateNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR ENDISCH RESEARCH QUANTIFICATION OF SEVERITY OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY IN POSTMORTEM BRAIN AUTOPSY TO IMPROVE NEUROPROGNOSTICATION AND TEMPERATURE CONTROL AFTER CARDIAC ARREST</GrantOrContributionPurposeTxt>
          <Amt>80000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S NATIONAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>111 MICHIGAN AVENUE</AddressLine1Txt>
            <CityNm>NM WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20010</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. TON - MECHANISM OF SELECTIVE VULNERABILITY IN THE THALAMIC RETICULAR NUCLEUS AFTER CARDIAC ARREST</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HIROSHIMA UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 CHOME-3-2 KAGAMIYAMA</AddressLine1Txt>
            <CityNm>HIGASHIHIROSHIMA</CityNm>
            <ProvinceOrStateNm>HIROSHIMA</ProvinceOrStateNm>
            <CountryCd>JA</CountryCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. NISHIKIMI RESEARCH SELECTIVE BRAIN HYPOTHERMIA COMBINED WITH CORE WARMING WITH AN ENDOVASCULAR DEVICES</GrantOrContributionPurposeTxt>
          <Amt>55000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JOHNS HOPKINS UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>MASON HALL 3400 N CHARLES ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21218</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. GARFINKEL - PARAMEDIC USE OF CAROTID ARTERY ULTRASOUND FOR PULSE CHECKS IN PATIENTS WITH OUT-OF-HOSPITAL CARDIAC ARREST - A FEASIBILITY STUDY</GrantOrContributionPurposeTxt>
          <Amt>26903</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JOHNS HOPKINS UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>MASON HALL 3400 N CHARLES ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21218</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR DING - INVESTIGATING A NOVEL NON-INVASIVE ULTRASONIC MEASURE OF CARDIAC OUTPUT FOR THE DIAGNOSIS OF CARDIOGENIC SHOCK</GrantOrContributionPurposeTxt>
          <Amt>23049</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MADIGAN ARMY MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9040A JACKSON AVE</AddressLine1Txt>
            <CityNm>JOINT BASE LEWISMCCHO</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>98431</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. LOW-TITE PUMIGLIA - USE OF IMMUNOADSORPTION FILTER FOR CONVERSION OF HIGH-TITER TO TYPE O WHOLE BLOOD</GrantOrContributionPurposeTxt>
          <Amt>49610</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 1ST STREET SW</AddressLine1Txt>
            <CityNm>ROCHESTER</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55905</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CHRISTOPH NABZDYK, MD - BIOADHESIVE PASTE FOR INSTANT HEMORRHAGE CONTROL OF VASCULAR AND SOLID ORGAN INJURIES - SHORTFALL</GrantOrContributionPurposeTxt>
          <Amt>4181</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 1ST STREET SW</AddressLine1Txt>
            <CityNm>ROCHESTER</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55905</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR HYDE RESEARCH PHYSIOLOGIC TARGETS FOR PULSELESS ELECTRICAL ACTIVITY</GrantOrContributionPurposeTxt>
          <Amt>57775</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MONASH UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WELLINGTON RD</AddressLine1Txt>
            <ProvinceOrStateNm>CLAYTON VIC</ProvinceOrStateNm>
            <CountryCd>AS</CountryCd>
            <ForeignPostalCd>3800</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MS. LANOS - A SYSTEMATIC SCOPING REVIEW OF INTERNATIONAL UNCONTROLLED DONATION AFTER CARDIAC DEATH (UDCD) PRACTICES AFTER OUT-OF-HOSPITAL CARDIAC ARREST</GrantOrContributionPurposeTxt>
          <Amt>14550</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RANDERS REGIONAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>SKOVLYVEJ 15</AddressLine1Txt>
            <ProvinceOrStateNm>RANDERS</ProvinceOrStateNm>
            <CountryCd>DA</CountryCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR RIIS RESEARCH NOVEL CARDIOPULMONARY RESUSCITATION TRAINING STRATEGIES TO IMPROVE</GrantOrContributionPurposeTxt>
          <Amt>10700</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE FEINSTEIN INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>350 COMMUNITY DR</AddressLine1Txt>
            <CityNm>MANHASSET</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11030</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR LI - ESTABLISHMENT OF A MULTICENTER VIDEO REVIEW REGISTRY TO ASSESS CHEST COMPRESSION INTERRUPTIONS DURING CARDIAC ARREST RESUSCITATION</GrantOrContributionPurposeTxt>
          <Amt>49836</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE FEINSTEIN INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>350 COMMUNITY DR</AddressLine1Txt>
            <CityNm>MANHASSET</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11030</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MR BIELAWA - ENTITLED "DETECTING RETURN OF SPONTANEOUS CIRCULATION USING FEMORAL ARTERIAL DOPPLER WAVEFORMS DURING CHEST COMPRESSIONS"</GrantOrContributionPurposeTxt>
          <Amt>49943</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE FEINSTEIN INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>350 COMMUNITY DR</AddressLine1Txt>
            <CityNm>MANHASSET</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11030</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. TAMBO, DR. CHUNYAN LI RESEARCH APPLICATION OF DIVING REFLEX IN A PORCINE MODEL OF ACUTE SHOCK</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE GENERAL HOSPITAL CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT ST</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02114</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. OKDA - REDUCING THE BURDEN OF MRSA PNEUMONIA IN POST CARDIAC ARREST PATIENTS USING HIGH DOSE INHALED NO IN AN EXPERIMENTAL SWINE MODEL A SYSTEMATIC SCOPING REVIEW OF INTERNATIONAL UNCONTROLLED DONATION AFTER CARDIAC DEATH (UDCD PRACTICES AFTER OUT-OF-HOSPITAL CARDIAC ARREST</GrantOrContributionPurposeTxt>
          <Amt>60694</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE MEDICAL UNIVERSITY OF VIENNA AUSTRIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>SPITALGASSE 23</AddressLine1Txt>
            <ProvinceOrStateNm>WIEN</ProvinceOrStateNm>
            <CountryCd>AU</CountryCd>
            <ForeignPostalCd>1090</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. SCHNAUBELT RESEARCH THE EFFECT OF EARLY LANDIOLOL IN PATIENTS WITH ST-ELEVATION ACUTE CORONARY SYNDROME UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTIONS - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE IV PILOT TRIAL (STEMILAND-1)</GrantOrContributionPurposeTxt>
          <Amt>25548</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1111 FRANKLIN STREET</AddressLine1Txt>
            <CityNm>OAKLAND</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94607</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EVAN GIUSTO - STUDY ENTITLED EVALUATION OF RESUSCITATION ALGORITHMS (NRP VS PALS) IN ASPHYXIATED CARDIAC ARREST OVINE MODEL OF DIFFERENT AGES</GrantOrContributionPurposeTxt>
          <Amt>49930</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNITY HEALTH TORONTO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ST JOSEPHS HEALTH CENTRE 30 THE</AddressLine1Txt>
            <AddressLine2Txt>QUEENSWAY</AddressLine2Txt>
            <CityNm>TORONTO</CityNm>
            <ProvinceOrStateNm>ONTARIO</ProvinceOrStateNm>
            <CountryCd>CA</CountryCd>
            <ForeignPostalCd>M6R 1B5</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR NOLAN RESEARCH A PROSPECTIVE OBSERVATIONAL STUDY OF SAFETY THREATS AND ADVERSE EVENTS IN TRAUMA (PRO-STAT)</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITE LIBRE DE BRUXELLES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>AV FRANKLIN ROOSEVELT 50</AddressLine1Txt>
            <ProvinceOrStateNm>BRUXELLES</ProvinceOrStateNm>
            <CountryCd>BE</CountryCd>
            <ForeignPostalCd>1050</ForeignPostalCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. PICOD RESEARCH MULTIMODAL ASSESSMENT OF ANGIOTENSIN II EFFECTS IN A SWINE MODEL OF POST-MYOCARDIAL INFARCTION CIRCULATORY FAILURE SUPPORTED BY VENO-ARTERIAL ECMO</GrantOrContributionPurposeTxt>
          <Amt>45000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF PITTSBURGH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4200 FIFTH AVE</AddressLine1Txt>
            <CityNm>PITTSBURGH</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>15260</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MR GUMUCIO - DOSE FINDING STUDY FOR OPTIMAL DOSE OF EARLY INTRAMUSCULAR EPINEPHRINE IN A PORCINE MODEL OF OUT-OF-HOSPITAL CARDIAC ARREST</GrantOrContributionPurposeTxt>
          <Amt>49271</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF PITTSBURGH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4200 FIFTH AVE</AddressLine1Txt>
            <CityNm>PITTSBURGH</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>15260</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. FLICKINGER - RESEARCH ASSESSING CHANGES IN MUSCLE HEALTH THROUGHOUT HOSPITALIZATION AFTER CARDIAC ARREST</GrantOrContributionPurposeTxt>
          <Amt>35815</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF PITTSBURGH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4200 FIFTH AVE</AddressLine1Txt>
            <CityNm>PITTSBURGH</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>15260</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR KRAEVSKY-PHILLIPS RESEARCH DATA-DRIVEN MODELING OF PATHOLOGICAL MECHANISMS OF DYSPNEA IN HEAR FAILURE</GrantOrContributionPurposeTxt>
          <Amt>49470</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF QUEENSLAND</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ST LUCIA</AddressLine1Txt>
            <ProvinceOrStateNm>QUEENSLAND</ProvinceOrStateNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. GILHOM RESEARCH ASSESSING SCHOOL READINESS OUTCOMES IN YOUNG CHILDREN ADMITTED TO THE PEDIATRIC INTENSIVE CARE UNIT USING MACHINE LEARNING AND POPULATION-BASED REGISTRY DATA IN QUEENSLAND, AUSTRALIA</GrantOrContributionPurposeTxt>
          <Amt>45790</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1300 YORK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10065</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. OWYANG VA-ECMO-SUPPORT - THE EFFECT OF PEEP ON RV FUNCTION IN ECPR: A PRE-CLINICAL SWINE MODEL</GrantOrContributionPurposeTxt>
          <Amt>85733</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ETHIOPIAN SOCIETY OF EMERGENCY AND CRITICAL CARE PROFESSIONALS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ADDIS ABABA</AddressLine1Txt>
            <CountryCd>ET</CountryCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MR ADDISIE - ASSESSMENT OF BASIC LIFE SUPPORT TRAINING AND WORK EXPERIENCE OF HEALTHCARE PROVIDERS IN LIMITED-RESOURCE SETTING: A QUALITY IMPROVEMENT PROJECT</GrantOrContributionPurposeTxt>
          <Amt>19440</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INSERM U942</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>7 RUE DE LA CROIX JARRY</AddressLine1Txt>
            <ProvinceOrStateNm>PARIS</ProvinceOrStateNm>
            <CountryCd>FR</CountryCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. DURAND - RESEARCH IMPACT OF SPATIOTEMPORAL REORGANIZATION OF RESIDENT MACROPHAGES ON TISSUE PHENOTYPE DURING SEPSIS</GrantOrContributionPurposeTxt>
          <Amt>30000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>OSLO UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>SOGNSVANNSVEIEN 20</AddressLine1Txt>
            <ProvinceOrStateNm>OSLO</ProvinceOrStateNm>
            <CountryCd>NO</CountryCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR. SVENSOY - HEMODYNAMICS AND HYPOXIC ORGAN DAMAGE DURING CARDIOPULMONARY RESUSCITATION WITH INFLATED AORTIC BALLOON CATHETER IN COMBINATION WITH INFUSION OF ORGAN PRESERVATION SOLUTION IN A PIG MODEL OF CARDIAC ARREST</GrantOrContributionPurposeTxt>
          <Amt>61000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE GRADUATE SCHOOL OF NIPPON SPORT SCIENCE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>7-1-1 FUKASAWA</AddressLine1Txt>
            <CityNm>SETAGAYAKU</CityNm>
            <ProvinceOrStateNm>TOKYO</ProvinceOrStateNm>
            <CountryCd>JA</CountryCd>
          </RecipientForeignAddress>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MS. TAKAHASHI - SUSTAINABLE EMERGENCY MEDICAL SYSTEMS AND RESUSCITATION STRATEGIES IN DEVELOPING COUNTRIES</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>34TH STREET</AddressLine1Txt>
            <CityNm>PHILADELPIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19104</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DR MITCHELL RESEARCH NATURAL LANGUAGE PROCESSING TO IDENTIFY IN-HOUSE CARDIAC ARREST</GrantOrContributionPurposeTxt>
          <Amt>48989</Amt>
        </GrantOrContributionPdDurYrGrp>
        <TotalGrantOrContriPdDurYrAmt>1561412</TotalGrantOrContriPdDurYrAmt>
        <TotalGrantOrContriApprvFutAmt>0</TotalGrantOrContriApprvFutAmt>
      </SupplementaryInformationGrp>
      <AnalysisIncomeProducingActyGrp>
        <DividendsAndInterestFromSecDtl>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>694897</ExclusionAmt>
        </DividendsAndInterestFromSecDtl>
        <GainSalesAstOthThanInvntryGrp>
          <ExclusionCd>18</ExclusionCd>
          <ExclusionAmt>114773</ExclusionAmt>
        </GainSalesAstOthThanInvntryGrp>
        <OtherRevenueDescribedGrp>
          <Desc>RETURNED GRANT FUNDS</Desc>
          <RelatedOrExemptFunctionIncmAmt>2000</RelatedOrExemptFunctionIncmAmt>
        </OtherRevenueDescribedGrp>
        <OtherRevenueDescribedGrp>
          <Desc>OTHER REVENUE</Desc>
          <ExclusionCd>14</ExclusionCd>
        </OtherRevenueDescribedGrp>
        <SubtotalsIncmProducingActyGrp>
          <UnrelatedBusinessTaxblIncmAmt>0</UnrelatedBusinessTaxblIncmAmt>
          <ExclusionAmt>809670</ExclusionAmt>
          <RelatedOrExemptFunctionIncmAmt>2000</RelatedOrExemptFunctionIncmAmt>
        </SubtotalsIncmProducingActyGrp>
        <TotalIncomeProducingActyAmt>811670</TotalIncomeProducingActyAmt>
      </AnalysisIncomeProducingActyGrp>
      <RlnOfActyToAccomOfExmptPrpsGrp>
        <RlnOfActyToAccomOfExmptPrpsGrp>
          <LineNumberTxt>11</LineNumberTxt>
          <RelationshipStatementTxt>EXCESS FUNDS RETURNED FROM GRANTS PREVIOUSLY PAID OUT.</RelationshipStatementTxt>
        </RlnOfActyToAccomOfExmptPrpsGrp>
      </RlnOfActyToAccomOfExmptPrpsGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>0</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>0</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>0</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>0</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>0</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>0</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>0</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>0</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>0</SharingOfFacilitiesEtcInd>
        <RelationshipsNonchrtblEOInd>0</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <AccountingFeesSchedule documentId="RetDoc2002200001">
      <AccountingFeesDetail>
        <CategoryTxt>ACCOUNTING FEES</CategoryTxt>
        <Amt>7000</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>7000</DisbursementsCharitablePrpsAmt>
      </AccountingFeesDetail>
    </AccountingFeesSchedule>
    <ExpenditureResponsibilityStmt documentId="RetDoc2118100001">
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>AARHUS UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>PALLE JUUL-JENSENS BOULEVARD 99</AddressLine1Txt>
          <CountryCd>DA</CountryCd>
        </ForeignAddress>
        <GrantDt>2023-03-07</GrantDt>
        <GrantAmt>27395</GrantAmt>
        <PurposeOfGrantTxt>MS. JOHANNSEN - RESEARCH PULMONARY VASODILATATION TO IMPROVE OUTCOME FOLLOWING CARDIAC ARREST - AN EXPERIMENTAL STUDY</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>27395</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>FEB. 13, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-02-13</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>AFFILIATED HOSPITAL OF XUZHOU MEDICAL UNIVERSITY</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>84 HUAIHAI WEST ROAD</AddressLine1Txt>
          <CityNm>XUZHOU</CityNm>
          <ProvinceOrStateNm>JIANGSU</ProvinceOrStateNm>
          <CountryCd>CH</CountryCd>
        </ForeignAddress>
        <GrantDt>2022-06-23</GrantDt>
        <GrantAmt>50000</GrantAmt>
        <PurposeOfGrantTxt>CHENGLEI SU, MD, PHD - RESEARCH "EXPLORE THE MECHANISM OF FERROPTOSIS ON POST-CARDIAC ARREST MYOCARDIAL DYSFUNCTION"</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>0</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>SEPT. 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-09-01</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>UNIVERSITY CLINICAL CENTRE OF THE REPUBLIC OF SRSPKA</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>Q5MHM8P</AddressLine1Txt>
          <CityNm>DVANAEST BEBA</CityNm>
          <ProvinceOrStateNm>BANJA LUKA</ProvinceOrStateNm>
          <CountryCd>BK</CountryCd>
        </ForeignAddress>
        <GrantDt>2022-06-23</GrantDt>
        <GrantAmt>29000</GrantAmt>
        <PurposeOfGrantTxt>TIJANA KOVACEVIC, PHARM D - RESEARCH "FEASIBILITY OF MUTI-DOMAIN DATA ACQUISITION IN PATIENTS AT RISK FOR HYPOXIC-ISCHEMIC BRAIN INJURY FOLLOWING CARDIAC ARREST"</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>29000</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>OCT. 2, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-10-02</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>KYOTO UNIVERSITY</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>YOSHIDAHONMACHI</AddressLine1Txt>
          <CityNm>SAKYO WARD</CityNm>
          <ProvinceOrStateNm>KYOTO</ProvinceOrStateNm>
          <CountryCd>JA</CountryCd>
        </ForeignAddress>
        <GrantDt>2022-07-11</GrantDt>
        <GrantAmt>50000</GrantAmt>
        <PurposeOfGrantTxt>YOHEI OKADA, MD PHD - RESEARCH MACHINE LEARNING BASED OPTIMIZATION STRATEGY FOR USE OF EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION IN OUT-OF-HOSPITAL CARDIAC ARREST</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>0</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>JULY 2, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-07-02</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>ADDIS ABABA UNIVERSITY</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>4KILLO KING GEORGE VI ST</AddressLine1Txt>
          <CityNm>ADDIS ABABA</CityNm>
          <CountryCd>ET</CountryCd>
          <ForeignPostalCd>NBH1</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2022-07-13</GrantDt>
        <GrantAmt>5100</GrantAmt>
        <PurposeOfGrantTxt>MERAHI KEFYALEW, MD - RESEARCH IMPROVING THE TIME TO PAIN RELIEF IN THE EMERGENCY DEPARTMENT THROUGH TRIAGE NURSE-INITIATED ANALGESIA: AN IMPLEMENTATION SCIENCE EVALUATED USING A QUASI-EXPERIMENTAL DESIGN</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>5100</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>MAR. 2, 2023</DatesOfReportsByGranteeTxt>
        <VerificationDt>2023-03-02</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>HARAMAYA UNIVERSITY IN ETHIOPIA</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>PO BOX 103 HARAMAYA UNIVERSITY</AddressLine1Txt>
          <CityNm>HARAR</CityNm>
          <CountryCd>ET</CountryCd>
        </ForeignAddress>
        <GrantDt>2022-12-22</GrantDt>
        <GrantAmt>10776</GrantAmt>
        <PurposeOfGrantTxt>DR. MELAKU GETACHEW - RESEARCH PROGNOSTIC IMPACT OF HYPOCHLOREMIA IN PATIENTS WITH ACUTE HEART FAILURE: PROSPECTIVE COHORT STUDY</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>10766</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>FEB. 9, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-02-09</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>SAINT PAUL'S HOSPITAL MILLENNIUM MEDICAL COLLEGE</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>GULELE SUB-CITY SWAZILAND STREET</AddressLine1Txt>
          <CityNm>ADDIS ABABA</CityNm>
          <CountryCd>ET</CountryCd>
        </ForeignAddress>
        <GrantDt>2022-12-22</GrantDt>
        <GrantAmt>5000</GrantAmt>
        <PurposeOfGrantTxt>MR JEGORA - RESEARCH UTILITY OF AN OBSTETRIC HIGH DEPENDENCY UNIT IN TERTIARY MEDICAL CENTER IN ETHIOPIA 2022</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>5000</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>SEPT. 30, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-09-30</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>SAINT LOUIS HOSPITAL IN PARIS</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>1 AVENUE CLAUDE VELLEFAUX</AddressLine1Txt>
          <CityNm>PARIS</CityNm>
          <CountryCd>FR</CountryCd>
          <ForeignPostalCd>75010</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2022-12-16</GrantDt>
        <GrantAmt>30000</GrantAmt>
        <PurposeOfGrantTxt>DR. LUPERTO - RESEARCH ENDOTHELIAL CELL IMMUNOGENICITY IN SEPSIS: STUDY ON A 3D MICROFLUIDIC MODEL WITH PULSED FLOW</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>23625</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>FEB. 17, 2025</DatesOfReportsByGranteeTxt>
        <VerificationDt>2025-02-17</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>MANCHESTER UNIVERSITY NHS FOUNDATION TRUST</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>COBBETT HOUSE MANCHESTER ROYAL</AddressLine1Txt>
          <AddressLine2Txt>INFIRMARY OXFORD R</AddressLine2Txt>
          <CityNm>MANCHESTER</CityNm>
          <CountryCd>UK</CountryCd>
          <ForeignPostalCd>M13 9WL</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2022-12-22</GrantDt>
        <GrantAmt>22930</GrantAmt>
        <PurposeOfGrantTxt>DR. TYRELL-MARSH - RESEARCH ARTERIAL BLOOD PRESSURE AND CARDIAC ARREST STUDY</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>0</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>FEB. 14, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-02-14</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF OXFORD</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>WELLINGTON SQUARE</AddressLine1Txt>
          <CityNm>OXFORD</CityNm>
          <CountryCd>UK</CountryCd>
          <ForeignPostalCd>OX1 2JD</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2022-12-22</GrantDt>
        <GrantAmt>34695</GrantAmt>
        <PurposeOfGrantTxt>DR. CROCKETT - RESEARCH HIGH-FLOW NASAL OXYGEN IN CARDIAC ARREST: A RANDOMIZED, CONTROLLED STUDY IN PIGS</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>25154</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>FEB. 13, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-02-13</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>AARHUS UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>PALLE JUUL-JENSENS BOULEVARD 99</AddressLine1Txt>
          <CountryCd>DA</CountryCd>
        </ForeignAddress>
        <GrantDt>2023-07-19</GrantDt>
        <GrantAmt>27615</GrantAmt>
        <PurposeOfGrantTxt>MS. LANGKILDE LAUESEN RESEARCH HANDOVER OF INFORMATION FROM WARD STAFF TO THE CARDIAC ARREST TEAM DURING IN-HOSPITAL CARDIAC ARREST: IDENTIFYING DEFICIENCIES AND BUILDING A NEW MODEL</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>0</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>SEPT. 15, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-09-15</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>AARHUS UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>PALLE JUUL-JENSENS BOULEVARD 99</AddressLine1Txt>
          <CountryCd>DA</CountryCd>
        </ForeignAddress>
        <GrantDt>2024-02-06</GrantDt>
        <GrantAmt>48836</GrantAmt>
        <PurposeOfGrantTxt>DR. JOHANNSEN - REDUCING NEUROLOGICAL INJURY FOLLOWING CARDIAC ARREST</PurposeOfGrantTxt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>REPORT DUE IN 1 YEAR.</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>AARHUS UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>PALLE JUUL-JENSENS BOULEVARD 99</AddressLine1Txt>
          <CountryCd>DA</CountryCd>
        </ForeignAddress>
        <GrantDt>2024-02-06</GrantDt>
        <GrantAmt>8500</GrantAmt>
        <PurposeOfGrantTxt>MR. JENNINGS - A NOVEL RISK ASSESSMENT TOOL FOR HYPERKALAEMIA AND DEVELOPMENT OF CARDIAC ARRHYTHMIA</PurposeOfGrantTxt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>REPORT DUE IN 1 YEAR.</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>AARHUS UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>PALLE JUUL-JENSENS BOULEVARD 99</AddressLine1Txt>
          <CountryCd>DA</CountryCd>
        </ForeignAddress>
        <GrantDt>2023-07-19</GrantDt>
        <GrantAmt>46726</GrantAmt>
        <PurposeOfGrantTxt>MR. NORHOLT - RESEARCH INTRAMUSCULAR EPINEPHRINE FOR THE TREATMENT OF CARDIAC ARREST</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>35837</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>OCT. 26, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-10-26</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>ANTWERP UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>DRIE EIKENSTRAAT 655</AddressLine1Txt>
          <ProvinceOrStateNm>EDEGEM</ProvinceOrStateNm>
          <CountryCd>BE</CountryCd>
          <ForeignPostalCd>2650</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-08-03</GrantDt>
        <GrantAmt>51597</GrantAmt>
        <PurposeOfGrantTxt>DR. VERDONCK - RESEARCH INJURY-SPECIFIC DIFFERENCES IN THE ADAMTS13-VWF AXIS IN MAJOR TRAUMA PATIENTS</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>0</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>OCT. 7, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-10-07</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>CHARITE - UNIVERSITATSMEDIZIN BERLIN</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>CHARITEPL 1</AddressLine1Txt>
          <ProvinceOrStateNm>BERLIN</ProvinceOrStateNm>
          <CountryCd>GM</CountryCd>
        </ForeignAddress>
        <GrantDt>2023-07-19</GrantDt>
        <GrantAmt>80000</GrantAmt>
        <PurposeOfGrantTxt>DR. ENDISCH - RESEARCH QUANTIFICATION OF SEVERITY OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY IN POSTMORTEM BRAIN AUTOPSY TO IMPROVE NEUROPROGNOSTICATION AND TEMPERATURE CONTROL AFTER CARDIAC ARREST</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>48405</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>OCT. 26, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-10-26</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>HIROSHIMA UNIVERSITY</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>1 CHOME-3-2 KAGAMIYAMA</AddressLine1Txt>
          <CityNm>HIGASHIHIROSHIMA</CityNm>
          <ProvinceOrStateNm>HIROSHIMA</ProvinceOrStateNm>
          <CountryCd>JA</CountryCd>
        </ForeignAddress>
        <GrantDt>2023-07-19</GrantDt>
        <GrantAmt>55000</GrantAmt>
        <PurposeOfGrantTxt>DR. NISHIKIMI - RESEARCH SELECTIVE BRAIN HYPOTHERMIA COMBINED WITH CORE WARMING WITH AN ENDOVASCULAR DEVICES</PurposeOfGrantTxt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>REPORT DUE IN 1 YEAR.</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>MONASH UNIVERSITY</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>WELLINGTON RD</AddressLine1Txt>
          <ProvinceOrStateNm>CLAYTON VIC</ProvinceOrStateNm>
          <CountryCd>AS</CountryCd>
          <ForeignPostalCd>3800</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2024-03-04</GrantDt>
        <GrantAmt>14550</GrantAmt>
        <PurposeOfGrantTxt>MS. LANOS - A SYSTEMATIC SCOPING REVIEW OF INTERNATIONAL UNCONTROLLED DONATION AFTER CARDIAC DEATH (UDCD) PRACTICES AFTER OUT-OF-HOSPITAL CARDIAC ARREST</PurposeOfGrantTxt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>REPORT DUE IN 1 YEAR.</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>RANDERS REGIONAL HOSPITAL</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>SKOVLYVEJ 15</AddressLine1Txt>
          <ProvinceOrStateNm>RANDERS</ProvinceOrStateNm>
          <CountryCd>DA</CountryCd>
        </ForeignAddress>
        <GrantDt>2023-07-19</GrantDt>
        <GrantAmt>10700</GrantAmt>
        <PurposeOfGrantTxt>DR. RIIS - RESEARCH NOVEL CARDIOPULMONARY RESUSCITATION TRAINING STRATEGIES TO IMPROVE</PurposeOfGrantTxt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>REPORT DUE IN 1 YEAR.</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>THE MEDICAL UNIVERSITY OF VIENNA AUSTRIA</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>SPITALGASSE 23</AddressLine1Txt>
          <ProvinceOrStateNm>WIEN</ProvinceOrStateNm>
          <CountryCd>AU</CountryCd>
          <ForeignPostalCd>1090</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-08-25</GrantDt>
        <GrantAmt>25548</GrantAmt>
        <PurposeOfGrantTxt>DR. SCHNAUBELT - RESEARCH THE EFFECT OF EARLY LANDIOLOL IN PATIENTS WITH ST-ELEVATION ACUTE CORONARY SYNDROME UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTIONS - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE IV PILOT TRIAL (STEMILAND-1)</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>0</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>SEPT. 9, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-09-09</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>UNITY HEALTH TORONTO</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>ST JOSEPHS HEALTH CENTRE 30 THE</AddressLine1Txt>
          <AddressLine2Txt>QUEENSWAY</AddressLine2Txt>
          <CityNm>TORONTO</CityNm>
          <ProvinceOrStateNm>ONTARIO</ProvinceOrStateNm>
          <CountryCd>CA</CountryCd>
          <ForeignPostalCd>16148</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-07-19</GrantDt>
        <GrantAmt>50000</GrantAmt>
        <PurposeOfGrantTxt>DR. NOLAN - RESEARCH A PROSPECTIVE OBSERVATIONAL STUDY OF SAFETY THREATS AND ADVERSE EVENTS IN TRAUMA (PRO-STAT)</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>16148</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>SEPT. 29, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-09-29</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>UNIVERSITE LIBRE DE BRUXELLES</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>AV FRANKLIN ROOSEVELT 50</AddressLine1Txt>
          <ProvinceOrStateNm>BRUXELLES</ProvinceOrStateNm>
          <CountryCd>BE</CountryCd>
          <ForeignPostalCd>1050</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2023-08-03</GrantDt>
        <GrantAmt>45000</GrantAmt>
        <PurposeOfGrantTxt>DR. PICOD - RESEARCH MULTIMODAL ASSESSMENT OF ANGIOTENSIN II EFFECTS IN A SWINE MODEL OF POST-MYOCARDIAL INFARCTION CIRCULATORY FAILURE SUPPORTED BY VENO-ARTERIAL ECMO</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>32024</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>OCT. 22, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-10-22</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF QUEENSLAND</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>ST LUCIA</AddressLine1Txt>
          <ProvinceOrStateNm>QUEENSLAND</ProvinceOrStateNm>
          <CountryCd>AS</CountryCd>
        </ForeignAddress>
        <GrantDt>2023-07-19</GrantDt>
        <GrantAmt>45790</GrantAmt>
        <PurposeOfGrantTxt>DR. GILHOM - RESEARCH ASSESSING SCHOOL READINESS OUTCOMES IN YOUNG CHILDREN ADMITTED TO THE PEDIATRIC INTENSIVE CARE UNIT USING MACHINE LEARNING AND POPULATION-BASED REGISTRY DATA IN QUEENSLAND, AUSTRALIA</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>11022</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>SEPT. 4, 2024</DatesOfReportsByGranteeTxt>
        <VerificationDt>2024-09-04</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>ETHIOPIAN SOCIETY OF EMERGENCY AND CRITICAL CARE PROFESSIONALS</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>ADDIS ABABA</AddressLine1Txt>
          <CountryCd>ET</CountryCd>
        </ForeignAddress>
        <GrantDt>2024-02-05</GrantDt>
        <GrantAmt>19440</GrantAmt>
        <PurposeOfGrantTxt>MR. ADDISIE - ASSESSMENT OF BASIC LIFE SUPPORT TRAINING AND WORK EXPERIENCE OF HEALTHCARE PROVIDERS IN LIMITED-RESOURCE SETTING: A QUALITY IMPROVEMENT PROJECT</PurposeOfGrantTxt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>REPORT DUE IN 1 YEAR.</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>INSERM U942</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>7 RUE DE LA CROIX JARRY</AddressLine1Txt>
          <ProvinceOrStateNm>PARIS</ProvinceOrStateNm>
          <CountryCd>FR</CountryCd>
        </ForeignAddress>
        <GrantDt>2024-03-22</GrantDt>
        <GrantAmt>30000</GrantAmt>
        <PurposeOfGrantTxt>DR. DURAND - RESEARCH IMPACT OF SPATIOTEMPORAL REORGANIZATION OF RESIDENT MACROPHAGES ON TISSUE PHENOTYPE DURING SEPSIS</PurposeOfGrantTxt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>REPORT DUE IN 1 YEAR.</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>OSLO UNIVERSITY HOSPITAL</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>SOGNSVANNSVEIEN 20</AddressLine1Txt>
          <ProvinceOrStateNm>OSLO</ProvinceOrStateNm>
          <CountryCd>NO</CountryCd>
        </ForeignAddress>
        <GrantDt>2024-02-05</GrantDt>
        <GrantAmt>61000</GrantAmt>
        <PurposeOfGrantTxt>DR. SVENSOY - HEMODYNAMICS AND HYPOXIC ORGAN DAMAGE DURING CARDIOPULMONARY RESUSCITATION WITH INFLATED AORTIC BALLOON CATHETER IN COMBINATION WITH INFUSION OF ORGAN PRESERVATION SOLUTION IN A PIG MODEL OF CARDIAC ARREST</PurposeOfGrantTxt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>REPORT DUE IN 1 YEAR.</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>THE GRADUATE SCHOOL OF NIPPON SPORT SCIENCE UNIVERSITY</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>7-1-1 FUKASAWA</AddressLine1Txt>
          <CityNm>SETAGAYAKU</CityNm>
          <ProvinceOrStateNm>TOKYO</ProvinceOrStateNm>
          <CountryCd>JA</CountryCd>
        </ForeignAddress>
        <GrantDt>2024-02-06</GrantDt>
        <GrantAmt>50000</GrantAmt>
        <PurposeOfGrantTxt>MS. TAKAHASHI - SUSTAINABLE EMERGENCY MEDICAL SYSTEMS AND RESUSCITATION STRATEGIES IN DEVELOPING COUNTRIES</PurposeOfGrantTxt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>REPORT DUE IN 1 YEAR.</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
    </ExpenditureResponsibilityStmt>
    <InvestmentsCorpStockSchedule documentId="RetDoc2018900001">
      <InvestmentsCorporateStockGrp>
        <StockNm>EQUITIES</StockNm>
        <EOYBookValueAmt>27086753</EOYBookValueAmt>
        <EOYFMVAmt>27086753</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
    </InvestmentsCorpStockSchedule>
    <OtherExpensesSchedule documentId="RetDoc2003200001">
      <OtherExpensesScheduleGrp>
        <Desc>BANK FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>50083</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>25041</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>25042</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>ADVERTISING</Desc>
        <RevenueAndExpensesPerBooksAmt>1326</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>1326</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>JOB MATERIALS</Desc>
        <RevenueAndExpensesPerBooksAmt>3500</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>3500</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>OFFICE EXPENSE</Desc>
        <RevenueAndExpensesPerBooksAmt>218</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>218</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>MA FORM PC FILING FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>250</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>250</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>DEDUCTIONS FROM K-1S</Desc>
        <RevenueAndExpensesPerBooksAmt>68053</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>68053</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>MISCELLANEOUS</Desc>
        <RevenueAndExpensesPerBooksAmt>93</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>93</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <OtherIncomeSchedule2 documentId="RetDoc2001500001">
      <OtherIncomeDetail>
        <Desc>RETURNED GRANT FUNDS</Desc>
        <RevenueAndExpensesPerBooksAmt>2000</RevenueAndExpensesPerBooksAmt>
        <AdjustedNetIncomeAmt>2000</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
    </OtherIncomeSchedule2>
    <OtherIncreasesSchedule documentId="RetDoc2049700001">
      <OtherIncreasesDetail>
        <Desc>UNREALIZED GAIN</Desc>
        <Amt>2665400</Amt>
      </OtherIncreasesDetail>
    </OtherIncreasesSchedule>
    <SubstantialContributorsSch documentId="RetDoc2089200001">
      <SubstantialContributorDetail>
        <BusinessName>
          <BusinessNameLine1Txt>ZOLL MEDICAL CORPORTATION</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>269 MILL ROAD</AddressLine1Txt>
          <CityNm>CHELMSFORD</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>01824</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <PersonNm>RICHARD A PACKER</PersonNm>
        <USAddress>
          <AddressLine1Txt>269 MILL ROAD</AddressLine1Txt>
          <CityNm>CHELMSFORD</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>01824</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <BusinessName>
          <BusinessNameLine1Txt>ASHAI KASEI CORPORATION</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>200 5TH AVENUE</AddressLine1Txt>
          <CityNm>WALTHAM</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02451</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
    </SubstantialContributorsSch>
    <TaxesSchedule documentId="RetDoc2002500001">
      <TaxesDetail>
        <CategoryTxt>MA ANNUAL REPORT</CategoryTxt>
        <Amt>19</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>19</DisbursementsCharitablePrpsAmt>
      </TaxesDetail>
    </TaxesSchedule>
  </ReturnData>
</Return>